The DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.
Chromoblastomycosis: an overview of clinical manifestations, diagnosis and treatment
Abstract
Chromoblastomycosis is one of the most frequent infections caused by melanized fungi. It is a subcutaneous fungal infection, usually an occupational related disease, mainly affecting individuals in tropical and temperate regions. Although several species are etiologic agents, Fonsecaea pedrosoi and Cladophialophora carrionii are prevalent in the endemic areas. Chromoblastomycosis lesions are polymorphic and must be differentiated from those associated with many clinical conditions. Diagnosis is confirmed by the observation of muriform cells in tissue and the isolation and the identification of the causal agent in culture. Chromoblastomycosis still is a therapeutic challenge for clinicians due to the recalcitrant nature of the disease, especially in the severe clinical forms. There are three treatment modalities, i.e., physical treatment, chemotherapy and combination therapy but their success is related to the causative agent, the clinical form and severity of the chromoblastomycosis lesions. There is no treatment of choice for this neglected mycosis, but rather several treatment options. Most of the patients can be treated with itraconazole, terbinafine or a combination of both. It is also important to evaluate the patient's individual tolerance of the drugs and whether the antifungal will be provided for free or purchased, since antifungal therapy must be maintained in long-term regimens. In general, treatment should be guided according to clinical, mycological and histopathological criteria.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Grant, S. M., & Clissold, S. P. (1990) · Drugs · doi:10.2165/00003495-199039060-00006 · Cited by 661
Chromoblastomycosis and phaeohyphomycosis: New concepts, diagnosis, and mycology
McGinnis, M. R. (1983) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(83)70001-0 · Cited by 463
Chromoblastomycosis: A review of 100 cases in the state of Rio Grande do Sul, Brazil
Minotto, R., Bernardi, C. D. V., Mallmann, L. F., Edelweiss, M. I. A., & Scroferneker, M. L. (2001) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2001.112220 · Cited by 218
Chromoblastomycosis: clinical and mycologic experience of 51 cases
Bonifaz, A., Carrasco‐Gerard, E., & Saúl, A. (2001) · Mycoses · doi:10.1046/j.1439-0507.2001.00613.x · Cited by 217
Self-citationTropical dermatology: Fungal tropical diseases
Lupi, O., Tyring, S. K., & McGinnis, M. R. (2005) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2004.10.883 · Cited by 211
Black fungi: clinical and pathogenic approaches
Hoog, G. S. D., Queiroz-Telles, F., Haase, G., Fernandez-Zeppenfeldt, G., Angelis, D. A., H. G. Gerrits van den Ende, A., Matos, T., Peltroche-Llacsahuanga, H., Pizzirani-Kleiner, A. A., Rainer, J., et al. (2000) · Medical Mycology · doi:10.1080/mmy.38.s1.243.250 · Cited by 170
Self-citationChromoblastomycosis: a retrospective study of 325 cases on Amazonic Region (Brazil)
da Silva, J. P., de Souza, W., & Rozental, S. (1998) · Mycopathologia · doi:10.1023/a:1006957415346 · Cited by 159
Posaconazole treatment of refractory eumycetoma and chromoblastomycosis
Negroni, R., Tobón, A., Bustamante, B., Shikanai-Yasuda, M. A., Patino, H., & Restrepo, A. (2005) · Revista do Instituto de Medicina Tropical de São Paulo · doi:10.1590/s0036-46652005000600006 · Cited by 158
Restrepo, Á. (1994) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(08)81277-7 · Cited by 148
Queiroz‐Telles, F., McGinnis, M. R., Salkin, I. F., & Graybill, J. R. (2003) · Infectious Disease Clinics of North America · doi:10.1016/s0891-5520(02)00066-1 · Cited by 139
Self-citation
Cited by
Histopathologic Diagnosis of Fungal Infections in the 21st Century
Guarner, J., & Brandt, M. E. (2011) · Clinical Microbiology Reviews · doi:10.1128/cmr.00053-10 · Cited by 1,007
Melanized Fungi in Human Disease
Revankar, S. G., & Sutton, D. A. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00019-10 · Cited by 569
Chowdhary, A., Meis, J. F., Guarro, J., de Hoog, G. S., Kathuria, S., Arendrup, M. C., Arikan-Akdagli, S., Akova, M., Boekhout, T., Caira, M., et al. (2014) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12515 · Cited by 374
Queiroz-Telles, F., de Hoog, S., Santos, D. W. C. L., Salgado, C. G., Vicente, V. A., Bonifaz, A., Roilides, E., Xi, L., Azevedo, C. D. M. P. E. S., da Silva, M. B., et al. (2017) · Clinical Microbiology Reviews · doi:10.1128/cmr.00032-16 · Cited by 360
Self-citationQueiroz-Telles, F., Fahal, A. H., Falci, D. R., Caceres, D. H., Chiller, T., & Pasqualotto, A. C. (2017) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30306-7 · Cited by 314
Self-citation
Metadata
- Authors
- Queiroz-Telles, F., Esterre, P., Perez-Blanco, M., Vitale, R. G., Salgado, C. G., & Bonifaz, A.
- Venue
- Medical Mycology
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-01
- Volume
- 47
- Issue
- 1
- Pages
- 3-15
- ISSN
- 0268-1218 (ISSN-L)
- 1369-3786
- 1460-2709
- OpenAlex
- W2107221099
- Cited by
- 333
- References
- 73
- FWCI
- 12.26
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Chromoblastomycosis: an overview of clinical manifestations, diagnosis and treatment. https://app.cochat.ai/papers/10.1080/13693780802538001
- The paper
- Queiroz-Telles, F., Esterre, P., Perez-Blanco, M., Vitale, R. G., Salgado, C. G., & Bonifaz, A. (2009). Chromoblastomycosis: an overview of clinical manifestations, diagnosis and treatment. Medical Mycology. https://doi.org/10.1080/13693780802538001
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.